<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03733873</url>
  </required_header>
  <id_info>
    <org_study_id>Suoquan in MNE</org_study_id>
    <nct_id>NCT03733873</nct_id>
  </id_info>
  <brief_title>Study on Chinese and Western Medicine in MNE Children</brief_title>
  <official_title>Study on the Therapeutic Schedule and Mechanism of Suoquan Mixture Combined With Desmopressin to Children's Monosymptomatic Enuresis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital of Fudan University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Monosymptomatic nocturnal enuresis (MNE) is a common pediatric developmental disorder. MNE&#xD;
      refers to urinary incontinence in the sleep state in children aged ≥5 years, without other&#xD;
      LUT symptoms, and without bladder dysfunction. Its pathogenesis mainly include overnight&#xD;
      polyuria, overactive bladder, sleep-arousal dysfunction, genetics, and abnormal secretion of&#xD;
      anti-diuretic hormone (ADH). Desmopressin is a synthetic analog of ADH arginine-vasopressin&#xD;
      (AVP), which is used to treat central diabetes insipidus and primary nocturnal enuresis&#xD;
      (PNE). Desmopressin decreases urine production at night when taken at bedtime. Insufﬁcient&#xD;
      ADH secretion at night will contribute to nocturnal polyuria, which is an important cause of&#xD;
      NE. Therefore, desmopressin, a synthetic analog of ADH, is frequently used for NE and is an&#xD;
      evidence-based therapy (grade ⅠA evidence). Some children, however, have desmopressin&#xD;
      resistance and do not achieve the desired treatment goals. What's more,there's a high relapse&#xD;
      rate of desmopressin after withdrawing. Suoquan mixture is a Chinese medicine commonly used&#xD;
      to treat NE in children. It is composed of Cuscuta, Codonopsis, Psoralea corylifolia Linn&#xD;
      ,Astragalus,mantis egg-case and ephedra. It has not only a certain cure rate but also has a&#xD;
      lower relapse rate . However there's few evidence could prove that. In this study,the&#xD;
      investigators compared the 3 month treatment response and relapse rate (RR) in the following&#xD;
      6 months of desmopressin and desmopressin plus suoquan, and observe if there will be a lower&#xD;
      relapse rare in desmopressin plus Suoquan. Moreover, the investigators will try to explore&#xD;
      the mechanism of Suoquan mixture in MNE.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Actual">July 30, 2020</completion_date>
  <primary_completion_date type="Actual">January 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>group1 desmopressin group2 desmopressin plus Suoquan mixture</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the relapse rate of MNE</measure>
    <time_frame>in 6 months after stopping drugs</time_frame>
    <description>If Suoquan mixture plus desmopressin could reduce the relapse rate of MNE</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">400</enrollment>
  <condition>Monosymptomatic Nocturnal Enuresis</condition>
  <arm_group>
    <arm_group_label>desmopressin plus Suoquan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drug1. name:desmopressin form:tablet dosage:2-4mg frequency:qn duration:3 months Drug2 name:Suoquan mixture form:liquid dosage:10ml/time frequence:bid duration:3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>desmopressin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>name:desmopressin form:tablet dosage:2-4mg frequency:qn duration:3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desmopressin</intervention_name>
    <description>take desmopressin for 3 months</description>
    <arm_group_label>desmopressin</arm_group_label>
    <arm_group_label>desmopressin plus Suoquan</arm_group_label>
    <other_name>Minirin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Suoquan</intervention_name>
    <description>take Suoquan mixture for 3 months</description>
    <arm_group_label>desmopressin plus Suoquan</arm_group_label>
    <other_name>Suoquan mixture</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  bedwetting occured ≥2nights/week,last for at least 3 months&#xD;
&#xD;
          -  without other LUT symptoms&#xD;
&#xD;
          -  without bladder dysfunction.&#xD;
&#xD;
          -  no treatment in last 3 months&#xD;
&#xD;
          -  signed the consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  had other LUT symptoms&#xD;
&#xD;
          -  with bladder dysfunction&#xD;
&#xD;
          -  had treatment in last 3 months&#xD;
&#xD;
          -  without the consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hong Xu, MD.PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of Fudan University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's hospital of Fudan university</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 6, 2018</study_first_submitted>
  <study_first_submitted_qc>November 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 7, 2018</study_first_posted>
  <last_update_submitted>March 9, 2021</last_update_submitted>
  <last_update_submitted_qc>March 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Children's Hospital of Fudan University</investigator_affiliation>
    <investigator_full_name>Hong Xu，MD.PhD</investigator_full_name>
    <investigator_title>chief physician</investigator_title>
  </responsible_party>
  <keyword>nocturnal enuresischildren</keyword>
  <keyword>Chinsese medicine</keyword>
  <keyword>children</keyword>
  <keyword>relapse rate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Nocturnal Enuresis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Deamino Arginine Vasopressin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

